Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Journal of Medicinal Chemistry
|
June 11, 2013
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant
Marco Radi, Cristina Tintori, Francesca Musumeci, et al.
Oncotarget
|
February 25, 2016
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
Cristina Talarico, Vincenzo Dattilo, Lucia D'Antona, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 19, 2019
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
Silvia Matteoni, Claudia Abbruzzese, Paola Matarrese, et al.
Journal of Medicinal Chemistry
|
December 4, 2014
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma
Cristina Tintori, Anna Lucia Fallacara, Marco Radi, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
April 15, 2015
SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation
Lucia D'Antona, Rosario Amato, Cristina Talarico, et al.
Bioorganic Chemistry
|
August 6, 2022
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment
Salvatore Di Maria, Francesca Picarazzi, Mattia Mori, et al.
Journal of Medicinal Chemistry
|
June 27, 2017
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model
Giulia Vignaroli, Giulia Iovenitti, Claudio Zamperini, et al.
Journal of Medicinal Chemistry
|
April 30, 2015
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors
Cristina Tintori, Giuseppina La Sala, Giulia Vignaroli, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Journal of Medicinal Chemistry
|
June 11, 2013
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant
Marco Radi, Cristina Tintori, Francesca Musumeci, et al.
Oncotarget
|
February 25, 2016
SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells
Cristina Talarico, Vincenzo Dattilo, Lucia D'Antona, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 19, 2019
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells
Silvia Matteoni, Claudia Abbruzzese, Paola Matarrese, et al.
Journal of Medicinal Chemistry
|
December 4, 2014
Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma
Cristina Tintori, Anna Lucia Fallacara, Marco Radi, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
April 15, 2015
SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation
Lucia D'Antona, Rosario Amato, Cristina Talarico, et al.
Bioorganic Chemistry
|
August 6, 2022
Novel pyrazolo[3,4-d]pyrimidines as dual Src/Bcr-Abl kinase inhibitors: Synthesis and biological evaluation for chronic myeloid leukemia treatment
Salvatore Di Maria, Francesca Picarazzi, Mattia Mori, et al.
Journal of Medicinal Chemistry
|
June 27, 2017
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model
Giulia Vignaroli, Giulia Iovenitti, Claudio Zamperini, et al.
Journal of Medicinal Chemistry
|
April 30, 2015
Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors
Cristina Tintori, Giuseppina La Sala, Giulia Vignaroli, et al.
Page
of 6